Alexander Monto is a Gastroenterology physician affiliated with San Francisco VA Health Care System. OpenAlex indexes 88 publications with 2,475 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Ucla Medical Plz Ste 365c
Los Angeles, CA 900950001
Telephone
310-821-1597Provider last certified this registry record 31 Jul 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20251 payment
- Madrigal PharmaceuticalsProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor100%Entecavir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2011–2019 per NIH RePORTER. The latest:
- Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes
Veterans Affairs Med Ctr San Francisco
FY2019I01CX000295 - Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes
Veterans Affairs Med Ctr San Francisco
FY2018I01CX000295 - Optimizing Hepatitis C Therapies and Predicting Liver Disease Outcomes
Veterans Affairs Med Ctr San Francisco
FY2017I01CX000295
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol‐associated cirrhosis
Alcoholism Clinical and Experimental Research
2024 - Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease
Digestive Diseases and Sciences
2024 - Alcohol Use Patterns During and After the COVID-19 Pandemic Among Veterans in the United States
The American Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”